Morphic Therapeutic NASDAQ:MORF Morphic Therapeutic is a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. In collaboration with AbbVie, Janssen, and Schrödinger, Morphic is advancing its pipeline and discovery activities using its proprietary MInT technology platform which leverages Morphic's unique understanding of integrin structure and biology.

Location: 35 Gatehouse Dr # A2, Massachusetts, 02451-1215, US | Website: morphictx.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing